Home > Insider Trading > Filing (0001203311-21-000043)

Filing Details

Accession Number:: 0001203311-21-000043
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-06-04 20:21:11
Reporting Period:: 2021-06-03

Accepted Time:: 2021-06-04 20:21:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1060736	Seagen Inc.	SGEN	Biological Products, (No Disgnostic Substances) (2836)	911874389

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1361966	B Vaughn Himes	21823 30Th Drive Se Bothell WA 98021	Chief Technical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-05-27	56,995	$0.00	72,894	No	5	G	Direct
Common Stock	Disposition	2021-05-27	9,941	$0.00	62,953	No	5	G	Direct
Common Stock	Disposition	2021-05-27	9,941	$0.00	53,012	No	5	G	Direct
Common Stock	Acquisiton	2021-06-03	10,697	$15.46	63,709	No	4	M	Direct
Common Stock	Disposition	2021-06-03	2,000	$142.42	61,709	No	4	S	Direct
Common Stock	Disposition	2021-06-03	2,318	$143.35	59,391	No	4	S	Direct
Common Stock	Disposition	2021-06-03	1,288	$144.61	58,103	No	4	S	Direct
Common Stock	Disposition	2021-06-03	2,800	$145.98	55,303	No	4	S	Direct
Common Stock	Disposition	2021-06-03	900	$147.05	54,403	No	4	S	Direct
Common Stock	Disposition	2021-06-03	1,391	$147.82	53,012	No	4	S	Direct
Common Stock	Acquisiton	2021-05-27	56,995	$0.00	110,664	No	5	G	Indirect	by Trust
Common Stock	Acquisiton	2021-05-27	9,941	$0.00	120,605	No	5	G	Indirect	by Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	G	Direct
No	5	G	Direct
No	5	G	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	5	G	Indirect	by Trust
No	5	G	Indirect	by Trust

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2021-06-03	10,697	$0.00	10,697	$15.46

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2021-08-24	No	4	M	Direct

Footnotes

On May 27, 2021, the reporting person transferred 56,995 shares of common stock to an irrevocable trust of which the reporting person is the trustee. The reporting person and members of the reporting person's family are the beneficiaries of the trust.
On May 27, 2021, the reporting person transferred 9,941 shares of common stock to an irrevocable trust of which the reporting person's spouse is the trustee. Members of the reporting person's family are the sole beneficiaries of the trust.
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Reflects sales of common stock executed in multiple transactions at prices ranging from $142.07 to $142.96 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of common stock executed in multiple transactions at prices ranging from $143.18 to $143.83 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of common stock executed in multiple transactions at prices ranging from $144.38 to $144.72 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of common stock executed in multiple transactions at prices ranging from $145.69 to $146.64 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of common stock executed in multiple transactions at prices ranging from $146.74 to $147.43 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of common stock executed in multiple transactions at prices ranging from $147.76 to $147.82 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Options vested at a rate of 25% on 8/24/12 and monthly thereafter until all the options were fully vested on 8/24/15.